Osteoboost's Chief Medical Officer Dr. Pamela Peeke, MD and Chief Product Officer Priya Patel join BHOF to discuss strategies to improve bone health.

Boomer Tech Talk explores Osteoboost’s FDA-cleared wearable for osteopenia, featuring insights from CSO Mike Jaasma, PhD and CPO Priya Patel.

NIA features Osteoboost, an FDA-cleared wearable delivering targeted vibration therapy to reduce bone loss in postmenopausal women with osteopenia.

Femtech Insider reports on Bone Health Technologies' acquisition of Wellen, enhancing Osteoboost's platform with personalized exercise-based osteoporosis care.

BioSpace reports on Bone Health Technologies acquiring Wellen to integrate personalized exercise programs with Osteoboost’s FDA-cleared vibration therapy.

Endocrine News spotlights Osteoboost, the first FDA-cleared wearable delivering targeted vibration therapy to slow bone loss in postmenopausal women.

Smart Design interviews Laura Yecies on Osteoboost’s FDA-cleared wearable, challenging “bikini health” bias in women’s bone health innovation.

Femtech Insider reports Bone Health Technologies raised $5M to launch Osteoboost, an FDA-cleared wearable reducing bone loss in postmenopausal women.

Medical Device News reports Bone Health Technologies raised $5M to launch Osteoboost, an FDA-cleared wearable reducing bone loss in postmenopausal women.

VatorNews reports Bone Health Technologies raised $5M to launch Osteoboost, an FDA-cleared wearable using NASA-inspired vibration therapy for bone health.

Techable highlights Osteoboost, an FDA-cleared wearable delivering targeted vibration therapy to slow bone loss in postmenopausal women.

MD+DI reports on FDA clearance of Osteoboost, the first non-drug prescription wearable using vibration therapy to reduce bone loss in postmenopausal women.